Gonorrhea – Pipeline Review, H2 2018 - Latest Pharmaceutical and Healthcare Disease Pipeline Guide

Summary
Latest Pharmaceutical and Healthcare disease pipeline guide Gonorrhea – Pipeline Review, H2 2018, provides an overview of the Gonorrhea (Infectious Disease) pipeline landscape.
Gonorrhea is an infection caused by a sexually transmitted bacterium that can infect both males and females. Gonorrhea most often affects the urethra, rectum or throat. In females, gonorrhea can also infect the cervix.
Gonorrhea Symptoms
The symptoms may include painful urination, pus-like discharge from the tip of the penis, increased vaginal discharge, painful urination, abdominal pain and pelvic pain. Treatment includes antibiotics.
Report Highlights
Latest Pharmaceutical market research report on “Gonorrhea – Pipeline Review, H2 2018” provides comprehensive information on the therapeutics under development for Gonorrhea (Infectious Disease), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The pipeline guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.
To know more in detailed, Browse Full Report:  Gonorrhea – Pipeline Review, H2 2018
Or Request a sample report:
Gonorrhea – Companies Involved in Therapeutics Development
  • Debiopharm International SA
  • Entasis Therapeutics Inc
  • Merck & Co Inc
  • Microbiotix Inc
  • Recce Ltd
Scope of the Report:
  • The pipeline guide provides a snapshot of the global therapeutic landscape of Gonorrhea (Infectious Disease).
  • The pipeline guide reviews pipeline therapeutics for Gonorrhea (Infectious Disease) by companies and universities/research institutes based on information derived from company and industry-specific sources.
  • The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
  • The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
  • The pipeline guide reviews key companies involved in Gonorrhea (Infectious Disease) therapeutics and enlists all their major and minor projects.
  • The pipeline guide evaluates Gonorrhea (Infectious Disease) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.
  • The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
  • The pipeline guide reviews latest news related to pipeline therapeutics for Gonorrhea (Infectious Disease)
Formulate corrective measures for pipeline projects by understanding Gonorrhea (Infectious Disease) pipeline depth and focus of Indication therapeutics.
Read Full Report:
Related Reports:

Sedation – Pipeline Review, H2 2018

Glaucoma – Pipeline Review, H1 2018

Chemotherapy Induced Anemia – Pipeline Review, H2 2018

Rosacea – Pipeline Review, H1 2018

Stroke – Pipeline Review, H2 2018

2018 Global Gonorrhea Testing Industry Report – History, Present and Future

Contact Us:
+91-9987295242

Comments

Popular posts from this blog

MHA – Neil Road Mixed-Use Complex – Singapore | The Ministry of Home Affairs, Singapore (MHA) plans to construct a mixed-use complex in Singapore.

Automated Material Handling Equipment Market in Europe 2018-2022

Rice Transplanter Market Status and Trend Report, 2013-2023